Aurinia Pharmaceuticals Inc - Common Shares (NQ:AUPH)

15.65 -0.18 (-1.11%)

Delayed Quote Updated: 11:23 AM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Aurinia Pharmaceuticals Inc - Common Shares

< Previous 1 2 3 4 5 6 7 8 9

...

12 13 Next >

Why Cineverse Shares Are Trading Lower By 18%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

June 30, 2023

Gainers Addentax Group Corp. (NASDAQ: ATXG) shares jumped 47.3% to $9.68. Addentax Group is launching automation of artificial intelligence internet operational tools project with top...

Via Benzinga

Carnival, SMART Global, Friedman Industries And Other Big Stocks Moving Higher On Friday ↗

June 30, 2023

U.S. stocks traded higher, with the Dow Jones gaining more than 200 points on Friday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Aurinia Surges As It Explores 'Strategic Alternatives,' Including A Potential Buyout ↗

June 30, 2023

The company makes a lupus nephritis treatment that could easily bolt onto a suitor, analysts say.

Via Investor's Business Daily

Aurinia Pharmaceuticals Earnings Perspective: Return On Capital Employed ↗

May 18, 2023

Via Benzinga

Aurinia Pharmaceuticals: Q1 Earnings Insights ↗

May 04, 2023

Via Benzinga

Why Aurinia Pharmaceuticals Stock Is Glowing Green Today ↗

April 11, 2023

Investors appear to be cheering another patent win by the company.

Via The Motley Fool

Why Are Aurinia Pharmaceuticals Shares Trading Higher Today ↗

June 30, 2023

Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) initiated an exploration of strategic alternatives, including a potential sale, merger, or

Via Benzinga

Why Renalytix Are Trading Higher By Over 48%; Here Are 20 Stocks Moving Premarket ↗

June 30, 2023

Gainers Renalytix Plc (NASDAQ: RNLX) shares surged 48.7% to $3.02 in pre-market trading after the company received FDA De Novo marketing authorization for its KidneyIntelX.dkd prognostic test.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

June 30, 2023

It's the final day of trading this week and we're starting off with a breakdown of the biggest pre-market stock movers worth watching today!

Via InvestorPlace

Tesla, Nike, Sigilon Therapeutics Among Top Trending Stocks Today ↗

June 29, 2023

Via Benzinga

Aurinia Board of Directors Announces Exploration of Strategic Alternatives to Maximize Shareholder Value

June 29, 2023

From Aurinia Pharmaceuticals Inc.

Via Business Wire

Aurinia Showcases Three Oral Presentations for LUPKYNIS® (voclosporin) at 2023 European Renal Association Annual Meeting in Milan, Italy

June 20, 2023

From Aurinia Pharmaceuticals Inc.

Via Business Wire

LUPKYNIS® (voclosporin) Achieved Significantly Higher Renal Response in Lupus Nephritis Patients with High Proteinuria Compared to Patients Treated with MMF and Low Dose Steroids Alone

June 01, 2023

From Aurinia Pharmaceuticals Inc.

Via Business Wire

Aurinia Files Form S-8 to Register Shares Underlying Previously Disclosed Inducement Awards for Newly Hired Employees

May 26, 2023

From Aurinia Pharmaceuticals Inc.

Via Business Wire

Aurinia Announces 2023 Annual General Meeting Results

May 17, 2023

From Aurinia Pharmaceuticals Inc.

Via Business Wire

Aurinia Pharmaceuticals Announces Kidney Biopsies Sub-study Data from the LUPKYNIS® (voclosporin) AURORA 2 Clinical Trial Presented at Congress of Clinical Rheumatology East Conference

May 09, 2023

From Aurinia Pharmaceuticals Inc.

Via Business Wire

Aurinia Pharmaceuticals Reports First Quarter 2023 Financial and Operational Results

May 04, 2023

From Aurinia Pharmaceuticals Inc.

Via Business Wire

Aurinia Pharmaceuticals Announces NICE Recommendation of LUPKYNIS® (Voclosporin) For Adults with Active Lupus Nephritis

May 03, 2023

From Aurinia Pharmaceuticals Inc.

Via Business Wire

Tesla, AMD, Ford, Starbucks, Aurinia Pharma: Why These 5 Stocks Are Drawing Investors' Attention Today ↗

May 02, 2023

Via Benzinga

ISS Joins Glass Lewis in Recommending Aurinia Shareholders Vote “FOR” ALL Company Director Nominees at 2023 Annual General Meeting

May 02, 2023

From Aurinia Pharmaceuticals Inc.

Via Business Wire

Aurinia Pharmaceuticals Announces Swissmedic Approval of LUPKYNIS® (voclosporin)

May 02, 2023

From Aurinia Pharmaceuticals Inc.

Via Business Wire

Glass Lewis Recommends Aurinia Shareholders Vote “FOR” ALL Company Director Nominees at 2023 Annual Meeting

April 28, 2023

From Aurinia

Via Business Wire

3 Biotechs That Might Get Bought Out in 2023 ↗

April 26, 2023

Biotech is expected to be a hotbed of mergers and acquisitions this year.

Via The Motley Fool

Toni Braxton and Aurinia Want People with Lupus Nephritis to Get Uncomfortable to Protect their Kidneys

April 25, 2023

From Aurinia Pharmaceuticals Inc.

Via Business Wire

Second Quarter Outlook For Biotech Stocks ↗

April 25, 2023

Biotech stocks have been consolidating recently but may be ready to rally higher due to factors such as a declining 10-year yield and growing M&A activity.

Via Talk Markets

Is Aurinia Pharmaceuticals Up for Grabs? Shareholder Suggests a Quick Sale for a Bigger Payday ↗

April 24, 2023

Via Benzinga

Aurinia Pharmaceuticals to Release First Quarter Financial and Operational Results on May 4, 2023

April 24, 2023

From Aurinia Pharmaceuticals Inc.

Via Business Wire

Aurinia Pharmaceuticals Announces New and Refined Method of Use Patent for LUPKYNIS® in the Treatment of Lupus Nephritis Issued by United States Patent and Trademark Office

April 11, 2023

From Aurinia Pharmaceuticals Inc.

Via Business Wire

3 Stocks That Already Doubled in 2023 and Could Keep Climbing ↗

April 11, 2023

The gains these stocks notched in the first few months of the year could be the beginning of a much longer bull run.

Via The Motley Fool

What's Going On With Aurinia Pharmaceuticals Stock Wednesday? ↗

April 05, 2023

Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) shares are trading higher Wednesday after the company announced "promising results" from its AURORA

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9

...

12 13 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.